David E. Joyce

Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis

David E. Joyce, Larry Gelbert, A Ciaccia et al. · Journal of Biological Chemistry · 2001 · 650 citations · Full text

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation

J. F. Dhainaut, S. Betty Yan, David E. Joyce et al. · Journal of Thrombosis and Haemostasis · 2004 · 427 citations

Thrombosis, Severe Sepsis, Hematology +8

Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni

Richard G. Wunderink, Sachin Yende, Pierre‐François Laterre et al. · CHEST Journal · 2003 · 246 citations

Critical Care Medicine, Severe Sepsis, Clinical Therapeutic +9

Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia

Bryce A. Kerlin, S. Betty Yan, Berend Isermann et al. · Blood · 2003 · 169 citations · Full text

Human Recombinant Activated Protein C in Meningococcal Sepsis

Gregory Wcisel, David E. Joyce, Arna Guðmundsdóttir et al. · CHEST Journal · 2002 · 29 citations

Medical Microbiology, Meningococcal Sepsis, Virulence Factor +6